Levodopa-Entacapone-Carbidopa Intestinal Gel in advanced Parkinson's disease: a single center experience

被引：0
|
作者：
Constantin, V.
Szatmari, S.
Orban-Kis, K.
Bataga, S.
Neagoe, R.
Ciorba, M.
Mihaly, I.
Kelemen, K.
Szasz, J.
机构：
来源：
MOVEMENT DISORDERS | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1382
引用
收藏
页码：S604 / S605
页数：2
相关论文
共 50 条
  • [1] Levodopa-Entacapone-Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson's Disease: A Single Center Real-World Experience
    Szatmari, Szabolcs
    Szasz, Jozsef Attila
    Orban-Kis, Karoly
    Baroti, Beata
    Bataga, Simona
    Ciorba, Marius
    Nagy, Elod Erno
    Neagoe, Radu Mircea
    Mihaly, Istvan
    Szasz, Peter Zsombor
    Kelemen, Krisztina
    Frigy, Attila
    Szilveszter, Monika
    Constantin, Viorelia Adelina
    PHARMACEUTICS, 2024, 16 (04)
  • [2] Two years' experience with levodopa-entacapone-carbidopa intestinal gel treatment in advanced Parkinson's disease
    Szatmari, Szabolcs
    Szasz, Jozsef Attila
    Constantin, Viorelia
    Mihaly, Istvan
    Torok, Arpad
    Ciorba, Marius
    Torok, Imola
    Kelemen, Krisztina
    Szasz, Peter
    Szilvester, Monika
    Baroti, Beata
    Frigy, Attila
    Orban-Kis, Karoly
    ORVOSI HETILAP, 2025, 166 (03) : 90 - 97
  • [3] Levodopa-Entacapone-Carbidopa Intestinal Gel Treatment in Advanced Parkinson's Disease: A Single-Center Study of 30 Patients
    Viljaharju, Vili
    Mertsalmi, Tuomas
    Pauls, K. Amande M.
    Koivu, Maija
    Eerola-Rautio, Johanna
    Udd, Marianne
    Pekkonen, Eero
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2024, 11 (02): : 159 - 165
  • [4] PROFILE OF PATIENTS WITH ADVANCED PARKINSON'S DISEASE TREATED WITH LEVODOPA-ENTACAPONE-CARBIDOPA INTESTINAL GEL (LECIG)
    Szasz, J.
    Constantin, V.
    Kis, K. Orban
    Bataga, S.
    Neagoe, R.
    Ciorba, M.
    Krisztina, K.
    Mihaly, I.
    Szatmari, S.
    PARKINSONISM & RELATED DISORDERS, 2024, 122
  • [5] Levodopa-entacapone-carbidopa intestinal gel infusion for advanced Parkinson's disease patients - data from a Romanian center
    Dulamea, A.
    Barbulescu, T.
    Banica, C.
    MOVEMENT DISORDERS, 2022, 37 : S446 - S446
  • [6] ELEGANCE - Prospective study of levodopa-entacapone-carbidopa intestinal gel (LECIG) in advanced Parkinson's disease
    Chaudhuri, K.
    Poewe, W.
    Ebersbach, G.
    Antonini, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 439 - 439
  • [7] Levodopa-Entacapone-Carbidopa Intestinal Gel in the treatment of advanced Parkinson's disease (PD): a two-year experience
    Szasz, J.
    Constantin, V.
    Orban-Kis, K.
    Bataga, S.
    Neagoe, R.
    Ciorba, M.
    Mihaly, I.
    Kelemen, K.
    Szatmari, S.
    MOVEMENT DISORDERS, 2024, 39 : S398 - S399
  • [8] Initial experience with levodopa-entacapone-carbidopa intestinal gel infusion (LECIG) for the management of advanced Parkinson's disease in Slovenia
    Pipan, E.
    Kriznar, N. Zupancic
    Ocepek, L.
    Rajnar, R.
    Kramberger, M.
    Menih, M.
    Pirtosek, Z.
    Trost, M.
    MOVEMENT DISORDERS, 2022, 37 : S463 - S464
  • [9] Levodopa-entacapone-carbidopa intestinal gel in Parkinson's disease: A randomized crossover study
    Senek, Marina
    Nielsen, Elisabet I.
    Nyholm, Dag
    MOVEMENT DISORDERS, 2017, 32 (02) : 283 - 286
  • [10] Levodopa-entacapone-carbidopa intestinal gel infusion in advanced Parkinson's disease: real-world experience and practical guidance
    Nyholm, Dag
    Jost, Wolfgang H.
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2022, 15
12345